T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Pulmonx
LUNG
$92.8M
| $344K | ﹤0.01% |
23,363
+2,377
| +11% | +$49K |
|
|
ORC
2377
Orchid Island Capital
ORC
$1.32B
| $344K | ﹤0.01% |
24,148
+6,701
| +38% | +$99.5K |
|
|
UHT
2378
Universal Health Realty Income Trust
UHT
$573M
| $341K | ﹤0.01% |
6,409
+88
| +1% | +$4.65K |
|
2379
Hyliion Holdings
HYLN
$734M
| $340K | ﹤0.01% |
105,463
-12,978
| -11% | -$45.5K |
|
|
LBAI
2380
DELISTED
Lakeland Bancorp Inc
LBAI
| $339K | ﹤0.01% |
23,175
+2,795
| +14% | +$42.9K |
|
|
INN
2381
Summit Hotel Properties
INN
$656M
| $338K | ﹤0.01% |
46,468
-1,525,020
| -97% | -$13.4M |
|
2382
SandRidge Energy
SD
$516M
| $336K | ﹤0.01% |
21,416
-11,984
| -36% | -$240K |
|
2383
TETRA Technologies
TTI
$1.25B
| $335K | ﹤0.01% |
82,540
-6,718
| -8% | -$29.6K |
|
2384
Veeco
VECO
$3.28B
| $335K | ﹤0.01% |
17,247
+287
| +2% | +$6.37K |
|
2385
Banc of California
BANC
$3.11B
| $334K | ﹤0.01% |
18,954
+399
| +2% | +$7.28K |
|
2386
Ameresco
AMRC
$1.47B
| $333K | ﹤0.01% |
7,316
-356,541
| -98% | -$19.8M |
|
2387
Willdan Group
WLDN
$1.29B
| $333K | ﹤0.01% |
12,067
+1,547
| +15% | +$42.3K |
|
|
VELO
2388
DELISTED
Velocity Acquisition Corp. Class A Common Stock
VELO
| $333K | ﹤0.01% |
33,986
| – | – |
|
2389
TTM Technologies
TTMI
$14.6B
| $332K | ﹤0.01% |
26,531
+2,921
| +12% | +$40.4K |
|
2390
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.3B
| $331K | ﹤0.01% |
800
| – | – |
|
2391
StoneCo
STNE
$2.49B
| $331K | ﹤0.01% |
43,044
+13,657
| +46% | +$131K |
|
2392
Motorcar Parts of America
MPAA
$235M
| $330K | ﹤0.01% |
25,176
+100
| +0.4% | +$1.49K |
|
2393
Washington Trust Bancorp
WASH
$767M
| $330K | ﹤0.01% |
6,827
+265
| +4% | +$12.9K |
|
|
CWEN.A
2394
DELISTED
Clearway Energy Class A
CWEN.A
| $329K | ﹤0.01% |
+10,300
| New | +$321K |
|
2395
iHeartMedia
IHRT
$464M
| $328K | ﹤0.01% |
41,524
+7,787
| +23% | +$105K |
|
2396
NRC Health Common Stock
NRC
$471M
| $328K | ﹤0.01% |
8,578
+1,571
| +22% | +$56.8K |
|
2397
TriMas Corp
TRS
$1.39B
| $328K | ﹤0.01% |
11,860
+149
| +1% | +$4.31K |
|
2398
MVB Financial
MVBF
$397M
| $325K | ﹤0.01% |
10,460
+77
| +0.7% | +$2.9K |
|
2399
Shore Bancshares
SHBI
$799M
| $325K | ﹤0.01% |
17,547
+5,397
| +44% | +$107K |
|
2400
TFS Financial
TFSL
$4.93B
| $324K | ﹤0.01% |
23,573
-27
| -0.1% | -$397 |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.